16 July 2026

Mannitol Salt Agar (MSA)

MSA Interactive Learning App
🧫 Mannitol Salt Agar (MSA) Interactive Learning System

Intended Use

Selective and differential medium for isolation of Staphylococci.

Principle

  • 7.5% NaCl inhibits most bacteria.
  • Mannitol differentiates fermenters.
  • Phenol red turns yellow in acidic conditions.

Composition

ComponentAmount/L
Peptone10 g
Beef Extract1 g
Mannitol10 g
Sodium Chloride75 g
Phenol Red0.025 g
Agar15 g
pH7.4 ±0.2

29 August 2024

5.3 Viral Classification: ICTV classification, Baltimore Classification and their comparison

5.3 Viral Classification: ICTV classification, Baltimore Classification and their comparison

5.3.1 ICTV Classification

Overview

The International Committee on Taxonomy of Viruses (ICTV) is the global authority responsible for the classification and nomenclature of viruses. Established in 1966, the ICTV aims to develop a universal taxonomic framework for viruses based on their evolutionary relationships, ensuring consistency in naming and classification across the scientific community.

Key Aspects of ICTV Classification

Hierarchical Structure

The ICTV classifies viruses into a hierarchical structure that includes the following taxonomic ranks:

  • Order: Ortervirales
  • Family: Retroviridae
  • Genus: Lentivirus
  • Species: Human immunodeficiency virus 1 (HIV-1)

Criteria for Classification

Viruses are classified based on several criteria, including:

  • Type of nucleic acid in the genome (DNA or RNA)
  • Genome structure (single-stranded or double-stranded, linear or circular)
  • Method of replication
  • Morphology
  • Host range
  • Phylogenetic relationships

Advances in molecular biology, particularly in genomics, have enabled more precise classification based on genetic sequencing.

Regular Updates and Revisions

The ICTV regularly updates its taxonomy to reflect new scientific discoveries. The classification system is dynamic, allowing the addition of new viral species, genera, families, and even orders as our understanding of viral diversity evolves.

Comprehensive Coverage

The ICTV system is designed to classify all known viruses, including those that infect animals, plants, fungi, bacteria, archaea, and other organisms.

5.3.2 Baltimore Classification

Overview

The Baltimore classification is a system proposed by Nobel laureate David Baltimore in 1971. It categorizes viruses based on their genomic structure and their replication strategy, particularly how they generate mRNA from their genomes. This system emphasizes the relationship between the viral genome and the host cell's machinery for protein synthesis.

Figure 1. The Baltimore Classification of Viruses (Image generated from Biorender.com by Admin)

Table 1. The Seven Classes of the Baltimore Classification

Class Genome Type Intermediate Step Final Product Examples
I dsDNA - mRNA → Protein Small Pox
II ssDNA ssDNA→ dsDNA mRNA → Protein Parvovirus
III dsRNA - mRNA → Protein Rotavirus
IV ssRNA (+) ssRNA (+) → ssRNA (-) mRNA → Protein Coronavirus
V ssRNA (-) - mRNA → Protein Measles
VI ssRNA (+) (RT) ssRNA (+) (RT)→ ssRNA (+) →dsRNA → dsDNA mRNA → Protein HIV
VII dsDNA (RT) dsDNA (RT)→ssRNA (+) →dsRNA → dsDNA mRNA → Protein Hepatitis B

Class I: Double-stranded DNA (dsDNA) Viruses

Viruses in this class have double-stranded DNA genomes. They utilize the host cell's DNA-dependent RNA polymerase to transcribe mRNA directly from their DNA.

Examples: Herpesviruses, Adenoviruses

Class II: Single-stranded DNA (ssDNA) Viruses

These viruses have single-stranded DNA genomes. Upon entering the host cell, the ssDNA is converted into double-stranded DNA, which is then transcribed into mRNA by the host’s enzymes.

Example: Parvoviruses

Class III: Double-stranded RNA (dsRNA) Viruses

Viruses in this class have double-stranded RNA genomes. The viral RNA-dependent RNA polymerase transcribes mRNA from the dsRNA genome.

Example: Reoviruses (e.g., Rotaviruses)

Class IV: Positive-sense Single-stranded RNA (+ssRNA) Viruses

These viruses have RNA genomes that can serve directly as mRNA. This RNA is immediately translated into proteins by the host's ribosomes.

Examples: Poliovirus, Coronaviruses

Class V: Negative-sense Single-stranded RNA (-ssRNA) Viruses

The genomes of these viruses are complementary to mRNA. A viral RNA-dependent RNA polymerase first synthesizes a positive-sense RNA (mRNA) from the negative-sense RNA genome, which is then translated into proteins.

Examples: Influenza virus, Ebola virus

Class VI: Retroviruses

Retroviruses have positive-sense single-stranded RNA genomes. However, instead of being directly translated, their RNA is reverse-transcribed into DNA by the viral enzyme reverse transcriptase. This DNA is integrated into the host genome, where it is transcribed into mRNA.

Example: HIV

Class VII: Double-stranded DNA (dsDNA) Viruses with Reverse Transcriptase

These viruses have double-stranded DNA genomes, but replicate through an RNA intermediate. The RNA is reverse-transcribed back into DNA, which is then integrated into the host genome.

Example: Hepatitis B virus (HBV)

5.3.4 Comparison of ICTV and Baltimore Classification

The ICTV classification provides a detailed taxonomy based on the evolutionary relationships and structural characteristics of viruses, categorizing them into various orders, families, genera, and species. On the other hand, the Baltimore classification focuses on the replication mechanisms of viruses, categorizing them into seven distinct groups based on their pathway of mRNA synthesis. Both classification systems are complementary and often used together to provide a comprehensive understanding of viral biology.

References

  • King, A. M. Q., Adams, M. J., Carstens, E. B., & Lefkowitz, E. J. (2012). Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press.
  • Baltimore, D. (1971). "Expression of Animal Virus Genomes." Bacteriological Reviews, 35(3), 235-241.
  • Knipe, D. M., & Howley, P. M. (Eds.). (2013). Fields Virology. Lippincott Williams & Wilkins.

25 February 2024

FASTA versus FASTQ

FASTA vs FASTQ: Bioinformatics File Formats

FASTA vs FASTQ: Bioinformatics File Formats

Format Structure

FASTA: In the FASTA format, each sequence entry begins with a single-line description, followed by lines of sequence data. The description line typically starts with a greater-than symbol ">" followed by an identifier and optionally a description or metadata. The sequence data can span multiple lines.

FASTQ: In the FASTQ format, each sequence entry consists of four lines:

  • Header line starting with "@" followed by an identifier and optionally additional information.
  • Sequence data represented by letters (A, C, G, T/U) indicating nucleotide bases.
  • A separator line usually represented by a plus sign "+".
  • Quality scores represented by ASCII characters, which reflect the confidence or probability of each base call in the sequence data.

Information Content

FASTA: FASTA files primarily contain sequence data and minimal metadata in the form of the description line.

FASTQ: FASTQ files contain not only sequence data but also quality scores corresponding to each base in the sequence. These quality scores are crucial for assessing the reliability of base calls generated during sequencing.

Quality Scores

FASTA: Since FASTA files do not include quality scores, there's no inherent information about the reliability or confidence of each base in the sequence.

FASTQ: Quality scores in FASTQ files provide information about the confidence level associated with each base call. These scores are typically represented using ASCII characters and can be used to assess the accuracy of sequencing data and to filter out low-quality reads.

Applications

FASTA: FASTA format is commonly used for representing sequence databases, sequence alignments, and other sequence-related data where quality information is not required.

FASTQ: FASTQ format is specifically designed for storing data generated by sequencing platforms such as Illumina, which produce both sequence data and corresponding quality scores. It's widely used in various bioinformatics applications including read mapping, variant calling, and de novo assembly where base call accuracy is crucial.

Examples

FASTA Example:

>Sequence1
ATCGGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTA
>Sequence2
CTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGCTAGC

FASTQ Example:
@SEQ_ID1
GATTTGGGGTTCAAAGCAGTATCGATCAAATAGTAAATCCATTTGTTCAACTCACAGTTT
+
!''*((((***+))%%%++)(%%%%).1***-+*''))**55CCF>>>>>>CCCCCCC65
@SEQ_ID2
TTGGCAGGCCAAGGCAGGCAGGCAGGCAGGCAGGCAGGCAGGCAGGCAGGCAGGCAGGCA
+
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC

Phred Scores

Phred scores are a commonly used way to represent the quality of base calls in DNA sequencing data. They are given as logarithmic probabilities, and higher scores correspond to greater levels of confidence in the base call's accuracy.

The formula to convert a Phred score (Q) to a probability (P) is:

P = 10^-Q/10

Conversely, the formula to convert a probability (P) to a Phred score (Q) is:
Q = -10 x log10(P)

In practice, Phred scores typically range from 0 to 40, although higher scores are possible. Here's what these scores represent:
  • A Phred score of 10 corresponds to a 1 in 10 chance (or 10%) of the base call being incorrect.
  • A Phred score of 20 corresponds to a 1 in 100 chance (or 1%) of the base call being incorrect.
  • A Phred score of 30 corresponds to a 1 in 1,000 chance (or 0.1%) of the base call being incorrect.
  • And so on.
These scores are widely used in bioinformatics for quality assessment and quality control of sequencing data. They are crucial for filtering out low-quality reads and improving the accuracy of downstream analyses such as variant calling and genome assembly.

References

  1. https://www.ncbi.nlm.nih.gov/genbank/fastaformat/
  2. https://emea.illumina.com/informatics/sequencing-data-analysis/sequence-file-formats.html
  3. https://doi.org/10.1016/B978-0-323-89775-4.00016-X.

23 February 2024

Bacteria are microorganisms that can cause a wide range of clinical infections in humans and animals. These infections can vary in severity from mild, self-limiting illnesses to life-threatening conditions. Here are some common bacterial pathogens and the clinical infections they can cause:

Staphylococcus aureus:
Clinical Infections: Skin and soft tissue infections (e.g., cellulitis, abscesses), pneumonia, bloodstream infections (bacteremia), endocarditis, osteomyelitis, food poisoning (due to toxin production).

Escherichia coli:
Clinical Infections: Urinary tract infections (UTIs), gastrointestinal infections (e.g., diarrhea, gastroenteritis), bloodstream infections (sepsis), pneumonia, meningitis (in neonates), urinary tract infections (UTIs), sepsis (especially in immunocompromised individuals).

Salmonella spp.:
Clinical Infections: Gastroenteritis (Salmonellosis), typhoid fever (caused by Salmonella Typhi and Salmonella Paratyphi A), bloodstream infections (bacteremia), focal infections (e.g., osteomyelitis), reactive arthritis (after enteric infections).

Clostridium difficile:
Clinical Infections: Antibiotic-associated diarrhea, pseudomembranous colitis, toxic megacolon, bloodstream infections (rare).

Clostridium botulinum:
Clinical Infections: Botulism (caused by ingestion of botulinum toxin), infant botulism (intestinal colonization by C. botulinum in infants), wound botulism (due to contamination of wounds).

Neisseria meningitidis:
Clinical Infections: Meningitis (acute bacterial meningitis), bloodstream infections (meningococcemia), septicemia, Waterhouse-Friderichsen syndrome (adrenal hemorrhage associated with meningococcemia).

Pseudomonas aeruginosa:
Clinical Infections: Pneumonia (especially in cystic fibrosis patients), urinary tract infections (UTIs), skin and soft tissue infections (especially in burns and wounds), bloodstream infections (especially in immunocompromised individuals), otitis externa ("swimmer's ear").

Helicobacter pylori:
Clinical Infections: Gastritis, peptic ulcer disease (duodenal and gastric ulcers), gastric adenocarcinoma, gastric mucosa-associated lymphoid tissue (MALT) lymphoma.

Mycobacterium tuberculosis:
Clinical Infections: Tuberculosis (pulmonary and extrapulmonary), including miliary TB, tuberculous meningitis, lymphadenitis, and disseminated disease (especially in immunocompromised individuals).

Chlamydia trachomatis:
Clinical Infections: Genital infections (urethritis, cervicitis, pelvic inflammatory disease), trachoma (chronic eye infection), neonatal conjunctivitis, lymphogranuloma venereum.

These are just a few examples of clinically significant bacterial pathogens and the infections they can cause. Treatment of bacterial infections typically involves antibiotics, although the choice of antibiotic may vary depending on the type of bacteria, the site of infection, and the patient's clinical condition. It's important to note that antibiotic resistance is a growing concern globally and can complicate the treatment of bacterial infections. Prompt diagnosis, appropriate antimicrobial therapy, and infection control measures are crucial in managing bacterial infections and preventing their spread.

Synthesis of Cell wall in bacteria

The cell wall is a critical structure in bacteria that provides shape, rigidity, and protection against osmotic lysis. It consists of a complex network of macromolecules, primarily peptidoglycan, along with other components such as lipopolysaccharides (in Gram-negative bacteria), lipoteichoic acids (in Gram-positive bacteria), and various proteins. Here's a detailed overview of the synthesis of the bacterial cell wall:
  1. Peptidoglycan Structure:

    • Peptidoglycan is the main component of the bacterial cell wall and consists of long glycan chains cross-linked by short peptide chains.
    • The glycan chains are composed of alternating units of N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM).
    • The peptide chains are attached to the NAM residues and consist of a variable amino acid sequence, typically containing both L- and D-amino acids.

  2. Initiation of Peptidoglycan Synthesis:

    • Peptidoglycan synthesis begins in the cytoplasm with the formation of the lipid II precursor molecule, which consists of a NAG-NAM-pentapeptide subunit attached to a lipid carrier molecule (bactoprenol).
    • The pentapeptide sequence of lipid II serves as the precursor for cross-linking during peptidoglycan synthesis.

  3. Translocation of Lipid II to the Cell Wall:

    • Lipid II is synthesized on the inner surface of the cytoplasmic membrane and is then translocated across the membrane to the outer surface, where peptidoglycan assembly occurs.
    • Bactoprenol transports lipid II across the membrane by flipping between the inner and outer leaflets, driven by the energy of pyrophosphate hydrolysis.

  4. Glycan Chain Elongation:

    • Once lipid II is on the outer surface of the membrane, it serves as the substrate for glycan chain elongation.
    • Glycosyltransferase enzymes catalyze the polymerization of additional NAG-NAM subunits onto the growing glycan chain, using the lipid II precursor as the donor substrate.

  5. Cross-Linking of Peptide Chains:

    • Transpeptidase enzymes (also known as penicillin-binding proteins, PBPs) catalyze the formation of cross-links between adjacent peptide chains, stabilizing the peptidoglycan network.
    • Transpeptidation involves the formation of peptide bonds between the D-alanine residue of one peptide chain and the meso-diaminopimelic acid (DAP) or D-alanine-D-alanine sequence of another peptide chain.

  6. Remodeling and Turnover:

    • Bacteria constantly remodel their cell walls to accommodate growth, division, and environmental changes.
    • Autolysins and endopeptidases cleave existing peptidoglycan bonds, allowing for the insertion of new glycan chains and cross-linking.
    • The balance between synthesis and degradation of peptidoglycan maintains cell wall integrity and facilitates cell growth and division.

Overall, the synthesis of the bacterial cell wall is a highly coordinated and dynamic process involving the sequential assembly of peptidoglycan components, translocation across the membrane, and cross-linking of peptide chains. Disruption of cell wall synthesis is a target for antibiotics such as beta-lactams, which inhibit transpeptidase activity and prevent cross-linking, leading to bacterial cell death.

Translation

Translation is the process by which genetic information encoded in messenger RNA (mRNA) is used to synthesize proteins. It involves decoding the nucleotide sequence of the mRNA into a specific sequence of amino acids, which are the building blocks of proteins. Here's a detailed overview of translation and its mechanisms:
  1. Initiation:

    • Translation begins with the assembly of the translation initiation complex, which consists of the small ribosomal subunit (40S in eukaryotes) bound to initiation factors and the initiator tRNA carrying methionine (tRNAiMet).
    • In prokaryotes, the small ribosomal subunit binds to the Shine-Dalgarno sequence on the mRNA, which helps position the ribosome at the start codon (usually AUG).
    • In eukaryotes, the small ribosomal subunit binds to the 5' cap structure of the mRNA, and the initiation complex scans along the mRNA until it recognizes the start codon in a favourable context (usually AUG).
  2. Elongation:

    • During elongation, the ribosome moves along the mRNA in a 5' to 3' direction, synthesizing the polypeptide chain.
    • Aminoacyl-tRNA synthetases charge tRNA molecules with their corresponding amino acids, forming aminoacyl-tRNA complexes.
    • The charged tRNA carrying the next amino acid binds to the A (aminoacyl) site of the ribosome, complementary to the mRNA codon.
    • Peptide bond formation occurs between the amino acid carried by the tRNA in the A site and the growing polypeptide chain attached to the tRNA in the P (peptidyl) site, catalyzed by peptidyl transferase activity in the large ribosomal subunit.
    • The ribosome translocates along the mRNA, moving the tRNA and mRNA by one codon (three nucleotides) and shifting the uncharged tRNA to the E (exit) site, where it is released.
  3. Termination:

    • Translation termination occurs when a stop codon (UAA, UAG, or UGA) is encountered in the mRNA.
    • Release factors (RFs) recognize the stop codon in the A site and promote the hydrolysis of the bond between the completed polypeptide chain and the tRNA in the P site.
    • The completed polypeptide is released from the ribosome, and the ribosomal subunits dissociate from the mRNA, marking the end of translation.
  4. Post-translational Modifications:

    • After translation, many proteins undergo post-translational modifications, including cleavage of signal peptides, addition of phosphate groups, glycosylation, lipidation, and proteolytic processing.
    • These modifications can affect protein stability, localization, activity, and interactions with other molecules.
  5. Regulation:

    • Translation is subject to regulation at multiple levels, including initiation, elongation, and termination.
    • Regulatory mechanisms can modulate the availability of translation factors, ribosome binding to mRNA, and the stability or accessibility of specific mRNAs, thereby controlling the rate and efficiency of protein synthesis in response to cellular conditions and external signals.

Overall, translation is a complex and highly regulated process that plays a central role in gene expression and protein synthesis. It allows cells to convert the genetic information stored in mRNA into functional proteins essential for cellular structure, function, and regulation.